SCHEMBL6948442

SCHEMBL6948442

Cc1nc(N2CCc3ccc(S(N)(=O)=O)cc3CC2)c([N+](=O)[O-])c(=O)[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.41
CA12 O43570 2/20 0.41
CA2 P00918 2/20 0.41
CA7 P43166 1/20 0.41
CA14 Q9ULX7 1/20 0.41
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
ADRA2A P08913 1/20 0.38
PNMT P11086 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
ALDH1A1 P00352 4/20 0.37
MAPT P10636 4/20 0.37
ROCK1 Q13464 1/20 0.35
HTT P42858 3/20 0.35
USP2 O75604 1/20 0.34
PTGS2 P35354 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
ATM Q13315 1/20 0.34
CA9 Q16790 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6953047 0.86 MAPT (0.38) ALDH1A1MAPTHTTATMGPR55
SCHEMBL6955056 0.85 PNMT (0.40) ADRA2APNMTADRA2BADRA2CALDH1A1
SCHEMBL6951360 0.84 LMNA (0.42) KDM4EGAAALDH1A1MAPTHTT
SCHEMBL6947740 0.84 TYMS (0.44) MAPTHTTKMT2ARPS6KB1
SCHEMBL6950817 0.84 TYMS (0.44) MAPTHTTGPR55LMNAMAPK1
SCHEMBL6952830 0.79 RAB9A (0.47) KDM4EGAAALDH1A1MAPTHTT
SCHEMBL6955100 0.78 MAPT (0.39) ALDH1A1MAPTHTTLMNAMAPK1
SCHEMBL6435436 0.76 MAPT (0.35) GAAALDH1A1MAPTHTTGPR55
SCHEMBL6951060 0.73 HTT (0.44) ALDH1A1MAPTHTTGPR55KMT2A
SCHEMBL6948586 0.72 TYMS (0.44) KDM4EALDH1A1MAPTHTTGPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed